Infect Immun 1991, 59:1739–1746.PubMed 21. Hijnen M, van Gageldonk PG, Berbers GA, van Woerkom T, Mooi FR: The Bordetella pertussis virulence factor P.69 pertactin retains its immunological BIX 1294 properties after overproduction in Escherichia coli. Protein Expr Purif 2005, 41:106–112.www.selleckchem.com/products/SB-202190.html CrossRefPubMed 22. Lee SF, Halperin SA, Knight JB, Tait A: Purification and

immunogeniCity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii. Appl Environ Microbiol 2002, 68:4253–4258.CrossRefPubMed 23. Roberts M, Fairweather NF, Leininger E, Pickard D, Hewlett EL, Robinson A, Hayward C, Dougan G, Charles IG: Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol 1991, 5:1393–1404.CrossRefPubMed 24. Mattoo S, Cherry JD: Molecular

pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18:326–382.CrossRefPubMed 25. Hellwig SM, Rodriguez ME, Berbers GA, Winkel JG, Mooi FR: Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003, 188:738–742.CrossRefPubMed 26. Cherry JD, Gornbein J, Heininger U, Stehr K: A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998, 16:1901–1906.CrossRefPubMed 27. Storsaeter J, Hallander HO, Gustafsson L, Olin P: Levels of anti-pertussis antibodies Mocetinostat ic50 related to protection after household exposure to Bordetella pertussis. Vaccine 1998, 16:1907–1916.CrossRefPubMed 28. Ausiello

CM, Lande R, Stefanelli P, Fazio C, Fedele G, Palazzo R, Urbani F, Mastrantonio P: T-cell immune response assessment as a complement to serology and intranasal protection Farnesyltransferase assays in determining the protective immunity induced by acellular pertussis vaccines in mice. Clin Diagn Lab Immunol 2003, 10:637–642.PubMed 29. Mills KH, Barnard A, Watkins J, Redhead K: Cell mediated immunity to Bordetella pertussis : role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993, 61:399–410.PubMed 30. Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG: Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Infect Immun 2006, 74:6797–6805.CrossRefPubMed 31. Medical Research Council: Vaccination against whooping cough: relation between protection in children and results of laboratory tests. Br Med J 1956, 2:454–462.CrossRef 32. Guiso N, Capiau C, Carletti G, Poolman J, Hauser P: Intranasal murine model of Bordetella pertussis infection .I. Prediction of protection in human infants by acellular vaccines. Vaccine 1999, 17:2366–2376.CrossRefPubMed 33.